Cell’s electrical charge
Ca-AEP is an essential factor for cell membrane integrity and cell sensitivity. It binds fatty acids and electrolytes to the cell membrane structure that generates the cell’s electrical charge. Studies over the past 30 years have shown that Ca-AEP is essential for neurotransmission, nerve impulse generation, and muscular contractions. Ca-AEP is one of a number of colamine phosphates—vitamin-like metabolites, it's a unique form of calcium. It has been shown to be effective in supporting a host of conditions, including multiple sclerosis, diabetes, asthma and immune disorders.
The first trial applications of Ca-AEP were for the treatment of multiple sclerosis (MS) in Germany in 1967. An analysis of more than 2,000 patients who were treated with colamine salts in Germany over the course of 24 years revealed greater efficacy from Ca-AEP treatments than other known treatments. Then in 1986, Dr. George Morrissette conducted retrospective poll of patients in the USA who originally had begun Ca-AEP treatment in Germany for MS. 82% of the almost 300 patients that entered the study showed a positive benefit from Ca-AEP therapy. And when treatment began in the early stages of MS, positive results rose to 92%.
Ca-AEP has produced good results in treating Insulin-dependent Diabetes Mellitus (IDDM), Non-insulin Dependent Diabetes Mellitus (NIDDM) and the complications of diabetes. The treatment of IDDM with Ca-AEP has resulted in lowered insulin requirements and in reduced sugar excretion. Ca-AEP’s therapeutic effect on diabetics is partly due to its inhibiting pancreatic autoimmune disorders. Ca-AEP has also improved the regulation of blood glucose in NIDDM. NIDDM is not a problem of reduced insulin production, but rather insulin resistance and an inability to transport glucose into cells. In such cases, eating excess carbohydrates causes an abnormal rise in blood sugar. If, on the other hand, the individual does not eat, hypoglycemia may result. When NIDDM patients are treated with Ca-AEP, this abnormality practically disappears, because glucose transport into cells is restore.
Some illnesses are initiated when the body is unable to synthesize and incorporate into cell membranes adequate amounts of colamine phosphates such as Ca-AEP. Conversely, restoring levels of Ca-AEP to proper levels has been shown to improve membrane integrity and produce actions that are both therapeutic and preventive in nature. Among the diseases initiated or influenced by disturbances in cellular membranes are: Multiple Sclerosis and sclerotic disorders, including Amyotrophic lateral sclerosis and progressive systemic sclerosis; Inflammatory disorders, including rheumatoid arthritis; Diabetes, both Insulin Dependent Diabetes Mellitus (IDDM) and Non-Insulin Dependent Diabetes Mellitus (NIDDM); Diabetic complications, including diabetic nephropathy and retinopathy; Osteoporosis; Lung diseases, including asthma, emphysema and other conditions characterized by poor gaseous exchange in the alveoli; Immune disorders such as sarcoidosis.
Dosages:
2 to 3 capsules per day
| Product Specifications: |
| Serving Size:1 Capsule |
| Amount Per Serving | % Daily Value |
| Calcium | 55mg | | 6% |
| (from calcium-2 AEP) |
| Phosphorus | 90mg | | 9% |
| (from calcium-2 AEP) |
| Calcium 2 AEP | 500mg | | * |
| (aminoethanol phosphate) |
| *Daily Value not established |
Other Ingredients:
Hydroxypropyl methylcellulose (Vcap).
Contains no added starch, salt, wheat, gluten,
corn, coloring, or dairy products.
Keep container tightly closed in a cool,
dry and dark place. Keep out of reach of children. |
